Overview
Keytruda Qlex is approved by the U.S. Food and Drug Administration (FDA) for the treatment of certain types of kidney cancer, also known as renal cell carcinoma (RCC). It is approved in combination with axitinib…
Overview
Keytruda is approved by the U.S. Food and Drug Administration (FDA) for the treatment of advanced renal cell carcinoma (RCC) in adults. It is used in combination with axitinib or lenvatinib as a first-line…